Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,200 | 8 | 69.1% |
| Food and Beverage | $3,168 | 177 | 30.4% |
| Education | $48.84 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $9,663 | 136 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $612.62 | 43 | $0 (2024) |
| ITI, Inc. | $80.23 | 3 | $0 (2023) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $61.33 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,134 | 38 | ABBVIE INC. ($2,934) |
| 2023 | $5,881 | 60 | ABBVIE INC. ($5,544) |
| 2022 | $836.52 | 53 | ABBVIE INC. ($619.84) |
| 2021 | $564.81 | 35 | AbbVie Inc. ($564.81) |
All Payment Transactions
186 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $113.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.84 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Central Nervous System | ||||||
| 08/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.17 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Central Nervous System | ||||||
| 06/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: NEUROSCIENCE | ||||||
| 06/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.56 | General |
| Category: Central Nervous System | ||||||
| 06/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: PSYCHIATRY | ||||||
| 05/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 35 | 104 | $15,600 | $4,845 |
| 2022 | 2 | 67 | 108 | $14,040 | $5,305 |
| 2021 | 1 | 42 | 144 | $15,840 | $7,590 |
| 2020 | 4 | 100 | 161 | $18,405 | $7,026 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 104 | $15,600 | $4,845 | 31.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 54 | $8,100 | $2,998 | 37.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 33 | 54 | $5,940 | $2,307 | 38.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 42 | 144 | $15,840 | $7,590 | 47.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 42 | 94 | $10,340 | $4,583 | 44.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 35 | $3,500 | $1,174 | 33.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 19 | $3,135 | $925.25 | 29.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 11 | 13 | $1,430 | $343.25 | 24.0% |
About Christopher Wolfe, PA-C
Christopher Wolfe, PA-C is a Medical healthcare provider based in Allentown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2008. The National Provider Identifier (NPI) number assigned to this provider is 1801046354.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Wolfe, PA-C has received a total of $10,417 in payments from pharmaceutical and medical device companies, with $3,134 received in 2024. These payments were reported across 186 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($7,200).
As a Medicare-enrolled provider, Wolfe has provided services to 244 Medicare beneficiaries, totaling 517 services with total Medicare billing of $24,765. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Allentown, PA
- Active Since 09/22/2008
- Last Updated 12/14/2011
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1801046354
Products in Payments
- VRAYLAR (Drug) $9,663
- AUSTEDO (Drug) $346.29
- Austedo XR (Drug) $266.33
- CAPLYTA (Drug) $141.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Allentown
Mrs. Danielle Westgate, Pa-C, PA-C
Medical — Payments: $8,545
Emily Nehme, Pa, PA
Medical — Payments: $7,143
Courtney Bloss, Pa, PA
Medical — Payments: $4,891
Tama Senick, Pa-C, PA-C
Medical — Payments: $4,508
Laura Pritz, Pa-C, PA-C
Medical — Payments: $4,326
Johanna Ziegler
Medical — Payments: $4,309